Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Making diversity in clinical research more than a talking point

By Brian Buntz | August 10, 2022

Stock art that suggests diversity in clinical research

[Image courtesy of Pixabay]

Not long ago, diversity in clinical research seemed like an obscure topic. Ben Enejo, a partner at Arthur D. Little, recalls mentioning the theme in the past and getting blank stares.

But the pandemic and the murder of George Floyd helped highlight the importance of diversity on multiple fronts, including in clinical research. As a result, there are growing collaborations between academia and the industry dedicated to the theme. The FDA has also released guidance on race and ethnicity.

In the U.S., about 75% of clinical trial participants were white in 2020, according to the FDA.

“Now, if you go back 20 years, I would say between 80% and 90% of clinical trials were not diverse,” Enejo said. “You could say we’re going in the right direction now.”

But while discussions on diversity in clinical research have escalated, “there’s a concern that companies are just [focused on diversity] to tick boxes,” Enejo said. “That negatively affects trust.”

To tackle the problem, pharmaceutical companies need to build community. “We need to get diverse populations enrolled in trials, stay in trials and be an advocate of those trials to others,” Enejo said.

A recent Pew Research study found that Black Americans were more likely than other U.S. adults to conclude that medical research misconduct is at least a moderately big problem.

Ben Enejo

Ben Enejo

Trust, of course, can be difficult to build and restore. “The first question a patient with a diverse background might have is, ‘Can I trust these guys?’ ‘Can I trust that they’re not using me to just fill a quota?'” Enejo said.

And trust remains a priority throughout the entire clinical trial process.

Some companies working to improve the diversity numbers of their clinical trials ensure their clinical research teams are diverse. It is vital that “diverse participants in clinical trials see someone who looks like them,” Enejo said.

Of course, diversity in clinical research is more than just a numbers game.

Clinical trial sponsors should work to enter into a dialogue with diverse clinical trial participants. Enejo recommended keeping in mind questions such as, ‘Can you help us fix this?’ ‘Can we collaborate?’

The goal is to “understand how we can build a better world together,” he added. “For me, that is quite a powerful theme, and it helps to build trust.”

Of course, improving diversity in clinical research will be a process. The industry is now in an awareness-generation phase. “We’re laying down the foundations required to enable the shift,” Enejo said.

Sponsors are also taking early steps to improve recruitment from underrepresented communities.

Regulators in Europe, the UK and the U.S. have issued guidance on diversity and inclusion in clinical trials.

Because diversity in clinical trials remains limited, it is vital that the industry shifts to the next phase, which involves “start setting targets and putting the infrastructure in place,” Enejo concluded.


Filed Under: clinical trials, Drug Discovery
Tagged With: diversity in clinical research
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE